5-hydroxytryptophan (5-HTP) is the immediate precursor to serotonin (5-HT, 5-hydroxytryptamine). Serotonin plays an important role in regulation of mood, appetite, body temperature, and the secretion of various hormones. While serotonin does not readily cross the blood brain barrier, serotonin precursors such as L-tryptophan and 5-HTP do. Supplementation with these precursors increases both central and peripheral levels of serotonin, and 5-HTP is generally seen as superior because it bypasses the rate-limiting step of serotonin synthesis (tryptophan hydroxylase) and absorption is not dependent on dietary factors [1]. 5-HTP also crosses into the CNS more easily, as L-tryptophan is limited by transporter availability and other factors [2]. Because 5-HTP successfully increases serotonin levels, it has been used for a variety of therapeutic purposes, primarily the treatment of depression [1].

Appetite suppression

One of the common uses of 5-HTP is as an appetite suppressant. 5-HTP administration to both humans and animals decreases food intake [3-4]. When given to rats in large amounts, 5-HTP decreased food intake by 68.9% [5]. Four clinical trials in overweight or obese humans have found 5-HTP to decrease food intake and consequently cause weight loss [6-7]. In a double-blind, placebo-controlled trial conducted by researchers at the University of Rome, 20 obese women were given 300 mg 5-HTP or placebo three times daily for six weeks of unrestricted diets followed by six weeks in which subjects were instructed to consume 1200 calories daily. The 5-HTP group experienced significant weight loss during both periods, and caloric intake was markedly reduced (1879 vs. 3220 calories during spontaneous eating, with a further reduction to 1268 calories during the second period) [7]. In another double-blind, placebo-controlled study on 20 overweight type II diabetes patients, subjects given 5-HTP had significant reductions in energy intake and body weight compared to plaecbo [6]. Although these dosages are large, it is presumable that lower doses of 5-HTP will also suppress appetite, albeit not as dramatically.

What’s remarkable about 5-HTP’s appetite suppressant effects is that it they are macronutrient-specific. It’s almost common knowledge that carbohydrate intake can make us sleepy by insulin assisted transport of tryptophan to the brain, leading to increased serotonin levels. Often when people are nervous, they crave carbohydrates, possibly due to their serotonin elevating properties. Thus, carbohydrate craving can be viewed as a deficit in serotonin [8]. Such a theory is supported by the observations in weight loss studies with 5-HTP, where carbohydrate calories were reduced, but not protein or fat calories [6]. Thus, 5-HTP could be helpful for those on low-carbohydrate diets.

There have been multiple mechanisms postulated for this effect of 5-HTP supplementation. Dieting causes a significant decrease in serotonin levels [7]. Serotonin may help suppress food intake by acting at serotonin receptors and by altering levels of certain hormones. 5-HTP induces the release of Corticotropin Releasing Factor (CRF), which increases energy expenditure while simultaneously decreasing energy intake [9]. Agonists of 5-HT1B, 5-HT2A, and 5-HT2C receptors such as DOI and mCPP cause appetite suppression in rats, an effect that may be due to actions at both central and peripheral serotonin receptors [4, 10].

While serotonin is the anti-carbohydrate neurotransmitter, norepinephrine is the “carbohydrate craving” neurotransmitter through its action on alpha-2 adrenoreceptors [11]. This often seems counterintuitive, as noradrenergic drugs are used for weight loss. However, stimulation of alpha-2 adrenoreceptors by norepineprhine or other agonists causes a decrease in serotonin synthesis which leads to carbohydrate craving [12]. This partially explains the synergistic effect on anorexia that yohimbine (an alpha-2 antagonist) produces with noradrenergic drugs. This observation also underlines the importance of serotonergic enhancement when using noradrenergic drugs (such as ephedrine) for dieting.

Studies in rodents indicate that 5-HTP administration causes a significant increase in the hormone leptin [3, 13]. Leptin plays an imporant role in the regulation of appetite and other physiological processes, and various factors can alter leptin secretion. 5-HTP administration results in significant increases in insulin, corticosterone, and prolactin levels, and all of these hormones can increase leptin levels [13]. The present animal research indicates that the the effect of 5-HTP on leptin levels are insulin-dependent, while the role that 5-HTP-induced increases in corticosterone plays seems to be minor [3, 13]. Future research should further define the mechanisms by which 5-HTP increases leptin levels.

Depression

The majority of the research on 5-HTP has focused on its possible use as a treatment for depression. In 2000, the clinical research was thoroughly reviewed by Meyers [2]. Many studies were conducted by a group of European researchers in the 1970's and early 1980's. In one study 60% of depressed patients given 5-HTP (200-3000 mg/day) improved while there were no improvements in the placebo group. Another double-blind study with 200 mg/day of 5-HTP indicated that it was more effective than placebo and almost as effective as the tricyclic antidepressant clomipramine. In 1977, a double-blind study was done with 5-HTP along with a drug to inhibit peripheral conversion to serotonin, and it found this combination to be equally as effective as the antidepressant imipramine. In both of these studies, 5-HTP was associated with fewer side effects than the other treatment [7]. Seven open studies were also conducted with positive results, however open studies are not good indicators of antidepressant effectiveness. In the 1970's, several other studies were also conducted in Japan in patients with various types of depression, all with positive results, but once again these were open studies.

In more recent research, a 1991 double-blind study in Switzerland compared 300 mg 5-HTP to fluvoxamine (Luvox) and found them to be equally effective in treating depression (although the results were in favor of 5-HTP, the difference was not statistically significant [7]). Most of these studies were in patients with major depression, although a double-blind study comparing L-tryptophan with a tricyclic antidepressant indicated that it was effective for mild and moderate depression, and it can be assumed that this benefit would cross over to 5-HTP. However, results from studies comparing 5-HTP with another antidepressant without a placebo group should be treated with caution. Two small studies conducted in the early 1980s indicated additive antidepressant effects with a combination of 5-HTP and tyrosine, a combination that warrants further exploration. At present, the bulk of the evidence indicates a benefit from 5-HTP supplementation in the treatment of depression, although a 2002 meta-analysis emphasizes the need for more studies with better methodology [14].

While it superficially makes sense that by increasing serotonin levels with 5-HTP would relieve depression, the antidepressant mechanism behind 5-HTP (and the SSRI’s) is slightly more complicated and constantly evolving with increasing research. An overactive HPA axis leading to increased cortisol levels has always been a hallmark of clinical depression, a phenomenon which can be reversed with successful antidepressant treatment [15]. Current research suggests that antidepressants, such as 5-HTP, might directly influence the normalization of HPA function and change the action of cortisol in the brain [16]. Acutely, 5-HTP induces the release of CRF and subsequently cortisol [17]. This would appear to exacerbate depressive symptoms, but the serotonin system is subject to tightly regulated negative feedback, especially when stimulated by 5-HTP [18]. Treatment with 5-HTP will lead to decreases in corticosteroid receptors in the rat brain [19].

The adrenal stimulation produced by 5-HTP might also be directly helpful to depression, as it raises Beta-Endorphin levels [20].

Insomnia

Although 5-HTP is commonly used for this purpose, research in humans is still largely lacking. An open study found that 600 mg 5-HTP increased REM sleep by 20 minutes in normal subjects, with a smaller effect with 200 mg [7]. There are theoretical reasons for a benefit, as high amounts of serotonin can cause tiredness (and other serotonergic agents such as trazodone are used to treat insomnia), and 5-HTP also increases melatonin levels by increasing serotonin, an effect that is more pronounced in the dark [21]. Preliminary human research and research with tryptophan indicates that 5-HTP may be of use in patients with obstructive sleep apnea [1, 22].

Other possible benefits

5-HTP may be useful in the treatment of chronic headaches, which have been linked to low serotonin levels. In a trial with 124 subjects, 5-HTP decreased the number of migraine headaches, but the difference was not statistically significant, while another study in 48 elementary and junior high school students indicated that 5-HTP reduced headache frequency by 70% compared to 11% for the placebo group [7]. 5-HTP may also be useful in patients with panic disorder as one placebo-controlled trial found it to reduce the panic reaction to CO2 challenge in patients with panic disorder [23]. Studies have also indicated miscellaneous benefits from 5-HTP supplementation in patients with fibromyalgia [24]. Reductions in serotonergic tone are partially responsible for cognitive deficits (memory loss) resulting from tetrahydrocannibinol (THC, the active component in marijuana). When given to rats, 5-HTP can significantly attenuate THC-induced memeory impairment [31].
Finally, 5-HTP is beneficial in animal models of Down syndrome and amyotrophic lateral scleroris, opening the door for human research [25].

Side effects and precautions

In clinical trials, the most commonly reported side effects are nause and gastrointestinal distress, and less commonly headaches and sleepiness [14, 17]. The nausea problem may be resolved by starting with a low dose and moving up, and even when large doses are used (900 mg/day), the problem diminishes with time [7].

Some of the hormonal effects of 5-HTP supplementation may not be desirable, although the relationships are complex. For example, 5-HTP increases cortisol secretion in healthy humans at doses as low as 100 mg [17, 26]. 5-HTP also causes an increase in prolactin concentrations in both animals and humans [3, 27]. These effects may be due to stimulation of 5-HT1A, 5-HT1C, 5-HT2, and possibly other 5-HT receptors [27-28]. The implications of these effects in the context of 5-HTP supplementation are not well known.

5-HTP should not be used along with prescription antidepressants without medical supervision or careful monitoring, as interactions are likely. 5-HTP potentiates the effects of SSRI's [29]. Serotonin syndrome is a concern, although a 12-month study of 200 mg 5-HTP along with an MAOI reported no incidences [7]. However, adverse reactions to the combination of tryptophan and Prozac have been reported [2], and serotonin syndrome has been reported with tryptophan and MAOI combinations [7].

Another concern is Eosinophilia-Myalgia Syndrome (EMS). This affected many users of tryptophan supplements in the late 1980's and resulted in multiple fatalities, and although it has been debated whether it was due to the tryptophan itself or a product impurity [14], contamination is now known to be the cause. Since 5-HTP is usually produced through extraction from plant sources, the same problem is not a likelihood. Two cases of EMS-like symptoms have been reported in patients taking 5-HTP; one was before product contamination was identified in 1990, and in the other case, product contamination was confirmed [7]. HPLC analysis has found some commercial preparations of 5-HTP to be contaminated, but it is unknown if this is the same contaminant that caused EMS [30]. For this reason, it is advisable to use 5-HTP from a brand with high product quality standards (such as the Now Foods brand).

Note: A few people have contacted me bringing up a concern voiced by a Dr. Steven B. Harris. According to Dr. Harris, 5-HTP supplementation is potentially dangerous because highly elevated levels of serotonin in the periphery have been linked to heart problems and other cardiovascular problems. Dr. Harris also says that the issue is greater when vitamin B6 supplements are taken because this catalyzes the converstion of 5-HTP to serotonin. As far as I know, Dr. Harris' contentions are unpublished, unreferenced, and have been voiced by no one other than himself. While researching for this article, we encountered no references to cardiovascular events following 5-HTP supplementation in either the primary or review literature. There also didn't appear to be any references to an interrelationship between vitamin B6 and 5-HTP supplements, although there is one report where monkeys were injected with amounts of vitamin B6 magnitudes higher than the amounts in oral supplements, and an increase in serotonin levels follows. While elevated levels of serotonin, or any other neurotransmitter, or pretty much any substance, can be harmful, it is important to first establish the concentrations at which they are harmful and whether or not a certain drug leads to those concentrations before drawing conclusions. As is the case with any supplement, one should always consult a doctor before taking 5-HTP if they have any condition or are taking any other prescription drugs, and discontinue use at first sign of an adverse reaction. -David

Recommended dosage

5-HTP is highly bioavailable, and about 70% reaches the bloodstream [7]. The half-life of 5-HTP is short (approximately 90 minutes [17]), so it should be taken three or more times daily if possible. It can be taken with or without food. The typical dosage is usually 50-100 mg three times daily, or for insomnia, 100-300 mg is taken before bed.